Page last updated: 2024-11-02

pargyline and Cardiomyopathies

pargyline has been researched along with Cardiomyopathies in 2 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with propranolol and pargyline protected against ISO-induced necrosis and myocardial hypertrophy, but did not influence the ISO-induced depletion of NE stores."1.25Alterations in norepinephrine pattern in the damaged myocardium in the rat. ( Bhagat, B; Dhalla, NS; Sullivan, JM, 1975)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhagat, B1
Sullivan, JM1
Dhalla, NS1
Sole, MJ1
Shum, A1
Van Loon, GR1

Other Studies

2 other studies available for pargyline and Cardiomyopathies

ArticleYear
Alterations in norepinephrine pattern in the damaged myocardium in the rat.
    Recent advances in studies on cardiac structure and metabolism, 1975, Volume: 6

    Topics: Animals; Cardiomegaly; Cardiomyopathies; Isoproterenol; Male; Monoamine Oxidase; Myocardium; Necrosi

1975
Serotonin metabolism in the normal and failing hamster heart.
    Circulation research, 1979, Volume: 45, Issue:5

    Topics: Animals; Cardiomyopathies; Cricetinae; Dihydroxytryptamines; Female; Heart Failure; Humans; Hydroxyd

1979